Investing.comQwen · 实盘不做把握 2/10不做原因:无增量信息
北京时间·🕒 发布 22:04:29·⟳ 抓取 22:09:13 +4m44s·⚡ 决策 08-25 22:12:36 +3m23s·62.9 天前
Leidos获美国海军健康研究中心5600万美元行为健康研究合同
$56M/66个月合同年化约$10.2M，仅占Leidos年收入$17.2B的0.06%、总市值约0.3-0.4%，属大型国防承包商的常规小型研究合同公告。按orders doctrine年化量级判断和megacap doctrine软催化门槛，该事件不构成可感知催化，无预期差，无短线交易edge。
📄 原文Investing.com↗ 原文
Leidos wins $56M Navy contract for military health research
Wall Street opens higher amid falling oil prices and Treasury yields RESTON, Va. - Leidos (NYSE:LDOS) announced today i…
不做 Leidos（LDOS.US）
合同年化约$10.2M，仅占年收入$17.2B的0.06%、总市值约0.3%，属大型国防承包商常规小型研究合同公告。按订单经验年化量级判断不构成可感知催化，无预期差，无短线交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Leidos获$56M/66个月海军行为健康研究合同，年化约$10.2M，仅占年收入$17.2B的0.06%。Leidos是年收入172亿美元的大型国防承包商，常规获得各类政府合同。按订单经验年化量级计算，该合同对收入和市值影响微乎其微（<0.1%），属常规业务公告而非增量催化。跨源检查未发现同一事件已被处理，但materiality本身不足以支撑任何方向的交易。
🔎 新鲜度:最早出现 2026-08-25 · 扩散 low · price-in 风险 low ↗
消息传播链
- Investing.com为聚合站，内容为Leidos官方新闻稿的AI辅助改写版本；合同金额过小，预计不会引起主流财经媒体关注
工具调用 · 历史记录,结果未知(5 种)
- fetch_decision_experience · 结果未知
- search_processed_events · 结果未知
- direct_instrument_candidates · 结果未知
- stock_quote · 结果未知
- web_search · 结果未知
原文全文
展开原文 · 1,564 字
Wall Street opens higher amid falling oil prices and Treasury yields
RESTON, Va. - Leidos (NYSE:LDOS) announced today it received a contract from the Naval Health Research Center to conduct behavioral health research and operational assessments for U.S. military personnel.
The contract has a total value of $56 million over a 66-month period, according to a press release statement. The work will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle.
Leidos will provide data-driven analyses and help translate scientific findings into solutions aimed at improving force readiness. The company will support research on psychological factors that impact military populations.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health.
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise. The center focuses on optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos is headquartered in Reston, Virginia, and employs approximately 50,000 people globally. The company reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
RESTON, Va. - Leidos (NYSE:LDOS) announced today it received a contract from the Naval Health Research Center to conduct behavioral health research and operational assessments for U.S. military personnel.
The contract has a total value of $56 million over a 66-month period, according to a press release statement. The work will focus on identifying risks and protective measures affecting the health, performance and readiness of military personnel throughout the deployment cycle.
Leidos will provide data-driven analyses and help translate scientific findings into solutions aimed at improving force readiness. The company will support research on psychological factors that impact military populations.
"This program reinforces the need for mission-critical health research in the military community," said Sarah McNichol, vice president of Behavioral Health & Readiness at Leidos Health.
The Naval Health Research Center is one of eight laboratories within the Navy Medical Research & Development Enterprise. The center focuses on optimizing operational readiness and health of U.S. armed forces through behavioral health, epidemiology, readiness, and disease surveillance.
Leidos is headquartered in Reston, Virginia, and employs approximately 50,000 people globally. The company reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。